Pro-inflammatory and T cell inhibitory cytokines are secreted at high levels in tumor cell cultures of human renal cell carcinoma

• Published in: European urology Vol. 35; no. 1; p. 70
• Main Authors: Lahn, M, Fisch, P, Köhler, G, Kunzmann, R, Hentrich, I, Jesuiter, H, Behringer, D, Muschal, B, Veelken, H, Kulmburg, P, Iklé, D N, Lindemann, A
• Format: Journal Article
• Language: English
• Published: Switzerland 01.01.1999
• Subjects: Biomarkers, Tumor; Carcinoma, Renal Cell - immunology; Carcinoma, Renal Cell - metabolism; Carcinoma, Renal Cell - pathology; Cytokines - biosynthesis; Cytokines - secretion; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Kidney Neoplasms - immunology; Kidney Neoplasms - metabolism; Kidney Neoplasms - pathology; Lymphocyte Activation; T-Lymphocytes - metabolism; Tumor Cells, Cultured
• ISSN: 0302-2838
• DOI: 10.1159/000019821

The objectives of this study were to assess cytokine secretion in human renal cell carcinoma (RCC) and to identify cytokines contributing to the immunomodulatory effect of tumor cells. Cytokine secretion in the supernatant of primary tumor cell cultures (PTCC) and corresponding cell lines (CL) was assayed using ELISA. Tumor cells were characterized by morphology, immunocytochemistry, and flow-cytometric analysis. Tumor-cell-induced T cell activation was determined by coculture of gamma delta and alpha beta T cell clones with tumor CL. We assessed the cytokine secretion of tumor cells from 27 PTCC and their corresponding CL (3/27) of RCC. We found that RCC predominantly produced both pro-inflammatory and T-cell-inhibitory cytokines, such as IL-8, IL-6, GM-CSF, TNF-alpha, IL-10 and TGF-beta 1. CL were adapted to serum-free medium which may prove as a useful tool in future studies of cytokine secretion in RCC. In addition, we used gamma delta and alpha beta T cell clones to assess the immunomodulatory effect of tumor cells from RCC and found that predominantly gamma delta T cells were activated by RCC. Our data suggest that RCC produce large amounts of both pro-inflammatory and T-cell-inhibitory cytokines that potentially could influence the immune response of the host, especially tumor-specific cytotoxic T cells.